Why does painkiller A work wonderfully for Mr. Miller, while Mrs. Smith only gets a stomachache from it? Classical medicine treats according to statistics: “Works for 80%.” But what if you belong to the other 20%?
We are currently experiencing a paradigm shift. Moving away from the “one-size-fits-all principle” toward “precision medicine.” The goal: the right drug, in the right dose, for the right patient, at the right time.
Pharmacogenetics: The Metabolic Inspection
Medications do not dissolve into thin air. They must be metabolized by the liver. Enzymes play a key role here, especially the family of Cytochrome P450 enzymes (CYP).
CYP1A2: The Caffeine Check
Not just important for drugs: CYP1A2 also determines how fast you break down coffee. Are you a “Slow Metabolizer”?
Every person has a genetically determined set of these enzymes. Four types are distinguished:
1. Ultrarapid Metabolizer
The turbo-metabolizer. They destroy active ingredients so quickly that no effect occurs. With painkillers like codeine (which must first be converted into morphine), there is a risk of a fatal overdose due to too rapid conversion.
2. Poor Metabolizer
The slow metabolizer. The drug accumulates in the body. At standard doses, severe side effects occur. Often these patients are wrongly labeled as “psychologically sensitive.”
The Key Players:
- CYP2D6: Processes approx. 25% of all drugs, including many antidepressants and beta-blockers.
- CYP2C19: Important for blood thinners (Clopidogrel) and acid blockers (PPIs).
Cancer: Unmasking the Enemy
Personalized medicine is most advanced in oncology. Previously, the diagnosis was simply “lung cancer.” Today we know: lung cancer is not just lung cancer. There are hundreds of subtypes, driven by different mutations.
Liquid Biopsy: Finding Cancer in the Blood
Instead of repeatedly punching painful tissue samples out of the lung, a blood sample (“liquid biopsy”) is often enough today. Tumors release tiny DNA snippets into the blood.
If, for example, a mutation is found in the EGFR gene, there is a pill that blocks exactly this switch in the tumor. The cancer shrinks without a chemotherapy poisoning the entire body.
Oncotype DX
A test for breast cancer that examines how genetically aggressive the tumor is. It can predict whether a woman really needs chemotherapy—or if it is useless to her and can be spared. Thousands of women are thus spared unnecessary suffering.
Rare Diseases: The End of the Odyssey
For patients with rare hereditary diseases, life was often a years-long journey from doctor to doctor. This is called a “Diagnostic Odyssey.” On average, it takes 7 years to reach a diagnosis.
Today, exome sequencing (reading all genes) can often find the needle in the haystack in weeks. Even if there is no cure yet: having the diagnosis ends the uncertainty and enables exchange with other affected people.
Conclusion: Investment in the Future
Personalized medicine is still expensive and complex. But it pays off. If a depression patient does not have to try out 5 medications until one works (and is unable to work for months in the process), but the genetic test immediately shows the right remedy, everyone wins.
The Future is Here: Gene Therapy
The logical next step after diagnosis is healing. Not through pills, but by repairing the cause.
Zolgensma: The most expensive drug in the world (approx. €2 million). It cures Spinal Muscular Atrophy (SMA) in babies. These children would otherwise agonizingly suffocate because their muscles waste away. Zolgensma uses a virus to bring a healthy copy of the gene into the cells. A single injection saves the life. This is the ultimate triumph of personalized medicine: we no longer treat symptoms; we correct the blueprint.
Liquid Biopsy vs. Tissue Sample
The advantage of “liquid biopsy” is not just comfort. Tumors are heterogeneous. A needle biopsy only pricks one spot and might only catch harmless cells. In the blood, we find DNA from all parts of the tumor (and the metastases). The picture is therefore more complete. In addition, the blood test can be repeated every few weeks to see if the therapy is working (monitoring). No one volunteers for a lung biopsy every few weeks.
HIV and the “Abacavir ID Card”
One of the greatest success stories of pharmacogenetics is the treatment of HIV. The drug Abacavir is highly effective. But: about 5-8% of patients carry a certain gene variant (HLA-B*5701).
If these patients are given Abacavir, their immune system overreacts. They develop severe allergic reactions that can be fatal on the second contact. Previously, this was a game of “Russian Roulette.” Today, testing for HLA-B*5701 is MANDATORY before the prescription is issued. Since then, there have been almost no deaths from this side effect. A simple test that saves lives.
Blood Thinners: The Warfarin Dosing Puzzle
Warfarin (Marcumar) is an important blood thinner to prevent strokes. But finding the dose is a nightmare. Too little: stroke. Too much: internal bleeding.
Two genes (CYP2C9 and VKORC1) determine nearly 40% of how fast a patient breaks down the drug. If these genes are known, the starting dose can be calculated exactly. One doesn’t have to try things out for weeks (“titrating”) while the patient is at risk. In the USA, this is almost standard; in Germany, it is slowly arriving.
Frequently Asked Questions
- What is pharmacogenetics?
- Pharmacogenetics examines how your genes influence the processing of medications. Some people break down active ingredients extremely fast (no effect), others not at all (danger of overdose).
- For which medications is this important?
- It is particularly relevant for antidepressants, blood thinners, painkillers, and certain cancer drugs.
- Do I need a special doctor for this?
- The field is growing. Many clinics offer specialized consultations, but primary care physicians can also order pharmacogenetic tests or incorporate the results into prescriptions.